Who are Feldan Therapeutics's investors?

Feldan Therapeutics's investors include Asahi Kasei Corporate Venture Capital, Genesys Capital, Linearis Ventures, Fonds de solidarité FTQ, Zynext Ventures.

Feldan Therapeutics

5 known investors

Find your way into Feldan Therapeutics

73 people in our graph share verified history with the Feldan Therapeutics team — schools, employers, funds. One of them is your warm intro.

Paras Sharmaunlockedknows François-Thomas Michaud · together at Feldan Therapeutics (overlapped)

×2knows the team · via Feldan Therapeutics

knows the team · via BIOQuebec

×8knows the team · via Université Laval

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.

Biotech Deep Tech Medical Devices

Founders & leadership

François-Thomas Michaud Board Member & Chief Executive OfficerFrançois-Thomas Michaud is CEO of Feldan Therapeutics, a clinical-stage biotech company developing peptide-based intracellular delivery technologies for therapeutic applications. He has more than 18 years of experience in biotech and life sciences, with expertise in partnership development and clinical program advancement.

Investors · 5

Asahi Kasei Corporate Venture Capitallisted by Asahi Kasei Corporate Venture CapitalMenlo Park · $200K – $5M

How we know: Asahi Kasei Corporate Venture Capital's portfolio page · Not right? Tell us

Genesys Capitallisted by Genesys CapitalToronto · $730K – $3.6M

How we know: Genesys Capital's portfolio page · funding news · finance.yahoo.com · Not right? Tell us

Linearis Ventureslisted by Linearis VenturesQuebec City

How we know: Linearis Ventures's portfolio page · funding news · press coverage · Not right? Tell us

Fonds de solidarité FTQreportedMontreal

How we know: funding news · finance.yahoo.com · Not right? Tell us

Zynext VenturesreportedPennington

How we know: funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountSeries BSep 2024
Fonds de solidarité FTQ (lead), Genesys Capital (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Feldan Therapeutics went on to found or lead other companies.

Paul F. TruexDirectorFounded Lqttrx +2 David J. MazzoChairman of the Board of DirectorsFounded Lisata Therapeutics, Inc.

Frequently asked questions

What does Feldan Therapeutics do?: Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.
Who are Feldan Therapeutics's investors?: Feldan Therapeutics's investors include Asahi Kasei Corporate Venture Capital, Genesys Capital, Linearis Ventures, Fonds de solidarité FTQ, Zynext Ventures.